← Open Payments lookup

TIMOTHY FORD: Open Payments

NPI 1053718197 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$807 in 35 payments from 12 companies in 2025. Trend: 2023 $562 · 2024 $1,434 · 2025 $807

Food & beverage: $807
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$215
Otsuka America Pharmaceutical, Inc.8$162
Neurocrine BioSciences, Inc.4$111
Teva Pharmaceuticals USA, Inc.4$88
E.R. Squibb & Sons, L.L.C.2$56
Tris Pharma Inc2$51
Janssen Pharmaceuticals, Inc1$26
Alkermes, Inc.1$23
Axsome Therapeutics, Inc.1$22
Luye Pharma (USA) Ltd.1$21

Products named: CAPLYTA, INGREZZA, REXULTI, UZEDY, COBENFY, Onyda XR, ABILIFY ASIMTUFII, INVEGA SUSTENNA.

Industry payments across TX — which companies pay providers there.